Evidence for the independence of immune responses to PF4 and the SARS-CoV-2 spike protein lie in the lack of increase in anti-PF4 antibodies and potential subsequent thrombocytopenia or thrombosis in former VITT patients who contracted COVID-19 later [79]. The gene discussed is PF4; the disease is COVID-19.